IL22 and cancer: Similar to our in vivo observations where IL‐22+/+/PyMT mice showed increased lung metastasis (Fig. 2E), IL‐22 treatment significantly increased both migration and invasion of cancer cells in vitro (P < 0.01; Fig. 3D–F).